Sphingosine kinase 1 gene transfer reduces postoperative peritoneal adhesion in an experimental model

British Journal of Surgery

Volumn 95, Issue 2, 2008, Pages 252-258

  Guo, Q ^a   Li, Q F ^b   Liu, H J ^b   Li, R ^a   Wu, C T ^b   Wang, L S ^b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYTOKERATIN; PHOSPHORUS 32; SPHINGOSINE KINASE 1; VIMENTIN; PHOSPHOTRANSFERASE; SPHINGOSINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CECUM; CELL DAMAGE; CELL ISOLATION; CELL MIGRATION; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; FEMALE; GENE; GENE ACTIVITY; LAPAROTOMY; MESOTHELIUM CELL; NONHUMAN; PERITONEUM ADHESION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SPK 1 GENE; UTERUS HORN; VIRAL GENE DELIVERY SYSTEM; ADENOVIRUS; ADHESION; ANIMAL; CELL CULTURE; GENE TRANSFER; GENETICS; METABOLISM; PATHOLOGY; PERITONEAL DISEASE; PERITONEUM; POSTOPERATIVE PERIOD; UTERUS; WESTERN BLOTTING; WISTAR RAT;

ADENOVIRIDAE; ADHESIONS; ANIMALS; BLOTTING, WESTERN; CECUM; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; GENE TRANSFER TECHNIQUES; PERITONEAL DISEASES; PERITONEUM; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); POSTOPERATIVE PERIOD; RATS; RATS, WISTAR; UTERUS;

EID: 38349142194     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.5890     Document Type: Article

References (20)

1. Menzies D, Ellis H. Intestinal obstruction from adhesions - how big is the problem? Ann R Coll Surg Engl 1990; 72: 60-63.
2. Menzies D. Postoperative adhesions: their treatment and relevance in clinical practice. Ann R Coll Surg Engl 1993; 75: 147-153.
3. Alponat A, Lakshminarasappa SR, Teh M, Rajnakova A, Moochhala S, Goh PM et al. Effects of physical barriers in prevention of adhesions: an incisional hernia model in rats. J Surg Res 1997; 68: 126-132.
4. Lisky C, Diamond M, Cunningham T, Constantine B, DeCherney AH, diZerega GS. Adhesion reduction in the rabbit uterine horn model using an absorbable barrier TC-7. J Reprod Med 1987; 32: 17-20.
5. Galili Y, Ben-Abraham R, Rabau M, Klausner J, Kluger Y. Reduction of surgery-induced peritoneal adhesions by methylene blue. Am J Surg 1998; 175: 30-32.
6. Cantürk NZ, Vural BC, Cubukcu A, Düzcen E, Utkan Z, Dülger M. Experimental study on the role of mast cells in peritoneal adhesion formation. East Afr Med J 1999; 76: 233-236.
7. Whitaker D, Papadimitriou JM, Walters MN. The mesothelium and its reactions: a review. Crit Rev Toxicol 1982; 10: 81-144.
8. Reijnen MM, Falk P, van Goor H, Holmdahl L. The antiadhesive agent sodium hyaluronate increases the proliferation rate of human peritoneal mesothelial cells. Fertil Steril 2007; 74: 146-151.
9. Liu HJ, Wu CT, Duan HF, Wu B, Lu ZZ, Wang LS. Adenoviral-mediated gene expression of hepatocyte growth factor prevents postoperative peritoneal adhesion in a rat model. Surgery 2006; 140: 441-447.
10. Warn R, Harvey P, Warn A, Foley-Comer A, Heldin P, Versnel M et al. HGF/SF induces mesothelial cell migration and proliferation by autocrine and paracrine pathways. Exp Cell Res 2001; 267: 258-266.
11. Duan HF, Wu CT, Lu Y, Wang H, Liu HJ, Zhang QW et al. Sphingosine kinase activation regulates hepatocyte growth factor induced migration of endothelial cells. Exp Cell Res 2004; 298: 593-601.
12. Herrick SE, Mutsaers SE. Mesothelial progenitor cells and their potential in tissue engineering. Int J Biochem Cell Biol 2004; 36: 621-642.
13. Takazawa R, Yamato M, Kageyama Y, Okano T, Kihara K. Mesothelial cell sheets cultured on fibrin gel prevent adhesion formation in an intestinal hernia model. Tissue Eng 2005; 11: 618-625.
14. Holmdahl L, Eriksson E, al-Jabreen M, Risberg B. Fibrinolysis in human peritoneum during operation. Surgery 1996; 119: 701-705.
15. Bertram P, Tietze L, Hoopmann M, Treutner KH, Mittermayer C, Schumpelick V. Intraperitoneal transplantation of isologous mesothelial cells for prevention of adhesions. Eur J Surg 1999; 165: 705-709.
16. Spiegel S, Cuvillier O, Edsall LC, Kohama T, Menzeleev R, Olah Z et al. Sphingosine-1-phosphate in cell growth and cell death. Ann N Y Acad Sci 1998; 845: 11-18.
17. Johnson KR, Johnson KY, Becker KP, Bielawski J, Mao C, Obeid LM. Role of human sphingosine-1-phosphate phosphatase 1 in the regulation of intra- and extracellular sphingosine-1-phosphate levels and cell viability. J Biol Chem 2003; 278: 34541-34547.
18. Lee H, Goetzl EJ, An S. Lysophosphatidic acid and sphingosine 1-phosphate stimulate endothelial cell wound healing. Am J Physiol Cell Physiol 2000; 278: C612-C618.
19. 2 promotes plasminogen activator inhibitor type 1 expression in human mesothelial cells. Surg Endosc 2003; 17: 1818-1822.
20. Maupas-Schwalm F, Augé N, Robinet C, Cambus JP, Parsons SJ, Salvayre R et al. The sphingomyelin/ceramide pathway is involved in ERK1/2 phosphorylation, cell proliferation, and uPAR overexpression induced by tissue-type plasminogen activator. FASEB J 2004; 18: 1398-1400.